Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 16314627

Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2005 Dec 1
First author
Haller DG

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Haller DG
      type
      Author
    2. name
      Catalano PJ
      type
      Author
    3. name
      Macdonald JS
      type
      Author
    4. name
      O'Rourke MA
      type
      Author
    5. name
      Frontiera MS
      type
      Author
    6. name
      Jackson DV
      type
      Author
    7. name
      Mayer RJ
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Haller DG
      type
      Author
    2. name
      Catalano PJ
      type
      Author
    3. name
      Macdonald JS
      type
      Author
    4. name
      O'Rourke MA
      type
      Author
    5. name
      Frontiera MS
      type
      Author
    6. name
      Jackson DV
      type
      Author
    7. name
      Mayer RJ
      type
      Author
    bibliography ids
    1. nci-bib-356c61ba4791073c90622cd9
    book metadata
    content sha256
    8102c2df9ce8872a6d90dead1037bf6fb93230d73c05d0511cebf6cf26ed266a
    document type
    citation
    dois
    1. 10.1200/JCO.2004.00.5686
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:16314627
    immutable id
    pubmed:16314627@8102c2df9ce8872a6d90dead1037bf6fb93230d73c05d0511cebf6cf26ed266a
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    Source null
    issn print
    0732-183X
    issue
    34
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    8671-8
    volume
    23
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      16314627
      provenance
      batch id
      a181c30258a88d182e78
      provider
      NCBI PubMed ESummary
      record sha256
      44d75871dca71125136ca923da1835c80da06d1e9ba3718357a789d112ac53bd
      response sha256
      558e0dce453ae424567844b062522ebd1d27363c3312c81dbf6f32a8ff08da24
      retrieved at
      2026-09-09T23:46:03.896343+00:00
      publication date
      display
      2005 Dec 1
      precision
      day
      year
      2005
      publication types
      1. Clinical Trial, Phase III
      2. Comparative Study
      3. Journal Article
      4. Randomized Controlled Trial
      5. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/16314627/
      title
      Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.

      Preserved source evidence · Not medical advice